China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. (SZSE:300294) for approximately CNY 360 million on August 29, 2023. Guangdong Fuda Pharmaceutical reported total assets of CNY 328,615,900 and Owner's equity of CNY 206,602,300 as at June 30, 2023. The transaction has been approved from board of China Resources Boya Bio-pharmaceutical and is still subject to approval from shareholders.

China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. (SZSE:300294) on September 25, 2023.